The Activation of the Sox2 RR2 Pluripotency Transcriptional Reporter in Human Breast Cancer Cell Lines is Dynamic and Labels Cells with Higher Tumorigenic Potential

The striking similarity displayed at the mechanistic level between tumorigenesis and the generation of induced pluripotent stem cells and the fact that genes and pathways relevant for embryonic development are reactivated during tumor progression highlights the link between pluripotency and cancer. Based on these observations, we tested whether it is possible to use a pluripotency-associated transcriptional reporter, whose activation is driven by the SRR2 enhancer from the Sox2 gene promoter (named S4+ reporter), to isolate cancer stem cells (CSCs) from breast cancer cell lines. The S4+ pluripotency transcriptional reporter allows the isolation of cells with enhanced tumorigenic potential and its activation was switched on and off in the cell lines studied, reflecting a plastic cellular process. Microarray analysis comparing the populations in which the reporter construct is active versus inactive showed that positive cells expressed higher mRNA levels of cytokines (IL-8, IL-6, TNF) and genes (such as ATF3, SNAI2, and KLF6) previously related with the CSC phenotype in breast cancer.

[1]  A. Gautam,et al.  STATE , 2016, Intell. Serv. Robotics.

[2]  H. Ng,et al.  Sox2: masterminding the root of cancer. , 2014, Cancer cell.

[3]  Steven J. M. Jones,et al.  Quiescent sox2(+) cells drive hierarchical growth and relapse in sonic hedgehog subgroup medulloblastoma. , 2014, Cancer cell.

[4]  S. Rorive,et al.  SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma , 2014, Nature.

[5]  B. Egleston,et al.  A requirement for Nedd9 in luminal progenitor cells prior to mammary tumorigenesis in MMTV-HER2/ErbB2 mice , 2014, Oncogene.

[6]  Beau Dabbs,et al.  Summary and discussion of : “ Controlling the False Discovery Rate : A Practical and Powerful Approach to Multiple Testing , 2014 .

[7]  F. Bertucci,et al.  ALDH1-positive cancer stem cells predict engraftment of primary breast tumors and are governed by a common stem cell program. , 2013, Cancer research.

[8]  R. Clarke,et al.  Targeting IL-8 signalling to inhibit breast cancer stem cell activity , 2013, Expert opinion on therapeutic targets.

[9]  E. Cuyás,et al.  Reprogramming of non-genomic estrogen signaling by the stemness factor SOX2 enhances the tumor-initiating capacity of breast cancer cells , 2013, Cell cycle.

[10]  David A. Orlando,et al.  Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes , 2013, Cell.

[11]  P. Knoepfler,et al.  Induced pluripotency and oncogenic transformation are related processes. , 2013, Stem cells and development.

[12]  K. Bussard,et al.  Human Breast Cancer Cells Are Redirected to Mammary Epithelial Cells upon Interaction with the Regenerating Mammary Gland Microenvironment In-Vivo , 2012, PloS one.

[13]  Yupo Ma,et al.  Identification of two novel phenotypically distinct breast cancer cell subsets based on Sox2 transcription activity. , 2012, Cellular signalling.

[14]  J. Visvader,et al.  Cancer stem cells: current status and evolving complexities. , 2012, Cell stem cell.

[15]  A. Pandiella,et al.  Sox2 expression in breast tumours and activation in breast cancer stem cells , 2012, Oncogene.

[16]  Wenjun Guo,et al.  Slug and Sox9 Cooperatively Determine the Mammary Stem Cell State , 2012, Cell.

[17]  C. López-Otín,et al.  Activation of AMP-activated protein kinase (AMPK) provides a metabolic barrier to reprogramming somatic cells into stem cells , 2012, Cell cycle.

[18]  D. Richel,et al.  The developing cancer stem-cell model: clinical challenges and opportunities. , 2012, The Lancet. Oncology.

[19]  Shan Zhu,et al.  NEDD9 Is a Positive Regulator of Epithelial-Mesenchymal Transition and Promotes Invasion in Aggressive Breast Cancer , 2011, PloS one.

[20]  André F. Vieira,et al.  Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype , 2011, Journal of Clinical Pathology.

[21]  Matt Thomson,et al.  Pluripotency Factors in Embryonic Stem Cells Regulate Differentiation into Germ Layers , 2011, Cell.

[22]  Paul A. Wiggins,et al.  Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state , 2011, Proceedings of the National Academy of Sciences.

[23]  M. Cilli,et al.  Oct-4+/Tenascin C+ neuroblastoma cells serve as progenitors of tumor-derived endothelial cells , 2011, Cell Research.

[24]  G. Smith,et al.  The normal mammary microenvironment suppresses the tumorigenic phenotype of mouse mammary tumor virus-neu-transformed mammary tumor cells , 2011, Oncogene.

[25]  K. Struhl,et al.  Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion , 2011, Proceedings of the National Academy of Sciences.

[26]  C. Lengerke,et al.  Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma , 2011, BMC Cancer.

[27]  R. Stephens,et al.  Increased NOS2 predicts poor survival in estrogen receptor-negative breast cancer patients. , 2010, The Journal of clinical investigation.

[28]  Stephen A. Ramsey,et al.  ATF3, an adaptive-response gene, enhances TGFβ signaling and cancer-initiating cell features in breast cancer cells , 2010, Journal of Cell Science.

[29]  H. Schöler,et al.  p53 connects tumorigenesis and reprogramming to pluripotency , 2010, The Journal of experimental medicine.

[30]  A. Ruiz i Altaba,et al.  NANOG regulates glioma stem cells and is essential in vivo acting in a cross‐functional network with GLI1 and p53 , 2010, The EMBO journal.

[31]  Joaquín Dopazo,et al.  Babelomics: an integrative platform for the analysis of transcriptomics, proteomics and genomic data with advanced functional profiling , 2010, Nucleic Acids Res..

[32]  M. Wolfson,et al.  NEDD9 promotes oncogenic signaling in mammary tumor development. , 2009, Cancer research.

[33]  T. Ichisaka,et al.  Suppression of induced pluripotent stem cell generation by the p53–p21 pathway , 2009, Nature.

[34]  D. Steindler,et al.  Expression of an exogenous human Oct-4 promoter identifies tumor-initiating cells in osteosarcoma. , 2009, Cancer research.

[35]  J. Rossant,et al.  Isolation of human iPS cells using EOS lentiviral vectors to select for pluripotency , 2009, Nature Methods.

[36]  F. Bertucci,et al.  Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. , 2009, Cancer research.

[37]  A. Sapino,et al.  Endothelial cell differentiation of human breast tumour stem/progenitor cells , 2008, Journal of cellular and molecular medicine.

[38]  M. McArthur,et al.  The transcription factor ATF3 acts as an oncogene in mouse mammary tumorigenesis , 2008, BMC Cancer.

[39]  A. Puisieux,et al.  Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition , 2008, PloS one.

[40]  Kristi A. Hohenstein,et al.  Regulation of Self‐Renewal and Pluripotency by Sox2 in Human Embryonic Stem Cells , 2008, Stem cells.

[41]  Wenjun Guo,et al.  The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.

[42]  M. Robles,et al.  University of Birmingham High throughput functional annotation and data mining with the Blast2GO suite , 2022 .

[43]  Charlotte Kuperwasser,et al.  Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy , 2008, Breast Cancer Research.

[44]  Kyung In Kim,et al.  Effects of dependence in high-dimensional multiple testing problems , 2008, BMC Bioinformatics.

[45]  Shulan Tian,et al.  Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.

[46]  J. Reis-Filho,et al.  Sox2: a possible driver of the basal-like phenotype in sporadic breast cancer , 2007, Modern Pathology.

[47]  Joaquín Dopazo,et al.  From genes to functional classes in the study of biological systems , 2007, BMC Bioinformatics.

[48]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[49]  Gordon K Smyth,et al.  Statistical Applications in Genetics and Molecular Biology Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2011 .

[50]  Terence P. Speed,et al.  A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..

[51]  Y. Benjamini,et al.  THE CONTROL OF THE FALSE DISCOVERY RATE IN MULTIPLE TESTING UNDER DEPENDENCY , 2001 .

[52]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[53]  J. Uriel.  Cancer, retrodifferentiation, and the myth of Faust. , 1976, Cancer research.

[54]  K. Illmensee,et al.  Totipotency and normal differentiation of single teratocarcinoma cells cloned by injection into blastocysts. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[55]  Wenjun Guo,et al.  Slug and Sox 9 Cooperatively Determine the Mammary Stem Cell State Citation , 2022 .